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Abstract
During pandemics, regular service provisioning processes in medical care may be disrupted. Digital health promises many 
opportunities for service provisioning during a pandemic. However, a broad penetration of medical processes with informa-
tion technology also has drawbacks. Within this work, the authors use the COVID-19 pandemic to analyze the chances and 
the risks that may come with using digital health solutions for medical care during a pandemic. Therefore, a multi-methods 
approach is used. First we use a systematic literature review for reviewing the state of the art of digital health applications in 
healthcare. Furthermore, the usage of digital health applications is mapped to the different processes in care delivery. Here 
we provide an exemplary process model of oncological care delivery. The analysis shows that including digital health solu-
tions may be helpful for care delivery in most processes of medical care provisioning. However, research on digital health 
solutions focuses strongly on some few processes and specific disciplines while other processes and medical disciplines are 
underrepresented in literature. Last, we highlight the necessity of a comprehensive risk-related debate around the effects that 
come with the use of digital healthcare solutions.
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1 Introduction
During the coronavirus disease (COVID-19) pandemic, digital 
solutions have proven to be able to strengthen our healthcare 
system in emergency situations [1]. However, the example of 
using tracing applications for gaining control over the spread 
of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) also showed that severe threats and risks may come 
with the utilization of digital solutions. Therefore, it needs 
to be carefully accessed where (fully) automated healthcare 
services are appropriate and where wide automation might 
not be reasonable [2]. This is especially relevant considering 
the increased vulnerability of the digital healthcare sector to 
cyberattacks during the COVID-19 pandemic [3].
The objective of this work is to provide an overview of 
the chances and risks taking a process-oriented perspective 
based on a multi-methods approach. In doing so our work 
provides a process model taking oncological care delivery 
as example and highlighting bottlenecks in care delivery 
during the pandemic. In order to get as comprehensive as 
possible an overview of the current state of research as well 
as of the range of promising devices, we conducted a sys-
tematic literature review investigating the usage of digital 
health solutions during the COVID-19 pandemic. We map 
the applied technologies to the respective processes discuss 
the chances and risks of implementing digital health applica-
tions in care delivery. The work intends to forward the sci-
entific discussion on the digitalization of healthcare systems 
and cost–benefit tradeoffs that need to be considered when 
implementing digital health technologies.
The article is organized as follows. Chapter 2 presents 
the theoretical background and related work focusing on 
SARS-CoV-2 and COVID-19, digital health, and healthcare 
processes. Thereafter, a model of oncological care deliv-
ery during the pandemic is developed. It shows the state of 
the art of care delivery and highlights the challenges and 
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specifics of healthcare during these times (e.g. bottlenecks). 
Chapter 4 provides a systematic literature review focusing 
on the utilization of digital solutions during the COVID-19 
pandemic and maps the usage of digital technologies to the 
processes of care delivery. Chapter 4 presents a cost benefit 
discussion on the usage of digital health systems giving a 
differentiated overview on the risks and the chances that 
come with a high dependency on digital technologies for 
healthcare delivery. Finally, chapter 5 concludes the work 
and derives some implications.
2  Theoretical background and related work
2.1  COVID‑19 and SARS‑CoV‑2
SARS-CoV-2 belongs to the community acquired respira-
tory viruses (CARV), which can cause upper and lower 
respiratory tract infections [4]. The virus was discovered 
in 2019 and describes a RNA-beta-coronavirus. COVID-
19, the disease caused by SARS-CoV-2, is linked to vari-
ous forms. While SARS-CoV-2 can cause asymptomatic 
infections it could also lead to severe forms of COVID-19 
including severe viral pneumonia, “massive alveolar damage 
and progressive respiratory failure” [5], as well as an acute 
respiratory distress syndrome which could even cause death 
[6]. Within the year 2020, COVID-19 reached a pandemic 
spread, challenging the health system of nations worldwide.
The containment of the virus and the control of the dis-
ease were very challenging as interventions to the pandemic 
spread of the virus comprised drastic measures like mobil-
ity restrictions, physical isolation and quarantine [6]. As 
drug development cycles were long, there was no cure to 
the virus for a long time. Thus, the treatment of COVID-19 
was largely symptomatic.
2.2  Healthcare processes, value and the healthcare 
value chain
Measuring the performance of any system needs to be based 
on a common goal of each actor within this system (objec-
tive function). For economic systems, i.e. markets and value 
chains, this common goal predominantly is value optimiza-
tion [7]. The term “value” describes the utility of process 
outcomes for the customers. “Value should be the preemi-
nent goal in the health care system, because it is what ulti-
mately matters for customers (patients) and unites the inter-
ests of all system actors. If value improves, patients, payers, 
providers, and suppliers can all benefit while the economic 
sustainability of the health care system improves. Value 
encompasses many of the other goals already embraced in 
health care, such as quality, safety, patient centeredness, and 
cost containment, and integrates them” [7]. Measuring this 
value starts with measuring the outcomes of health care. 
Thereby healthcare processes take a prominent role in the 
causality chain, which predominantly comprises processes 
of medical intervention (e.g. diagnosing or patient treatment) 
as so called primary value processes but also organizational 
processes (e.g. disinfection and cleaning) as so called sec-
ondary value processes. It is therefore essential to control 
processes as the source of value generation. Discussions 
about how to improve healthcare value and about the influ-
ence of technologies on healthcare need both to be based on 
the process level. Hence, modelling healthcare processes is 
essential for elaborating on the effects on healthcare value 
and understanding healthcare value generation.
2.3  Digital health
“Digital health comprises overlapping areas ranging from 
AI, the internet of things, electronic health, and telehealth 
to the analysis and use of big data” [2]. This technological 
(r)evolution of the healthcare branch is said to be able to 
“support the provision of effective and efficient health care 
services” [8] and to stabilize the costs of healthcare delivery 
[8]. Furthermore, the digitalization of health delivery could 
enable holistic, personalized and precision medicine even for 
hard-to-reach-populations. Besides many different technolo-
gies for the digitalization of medicine, wearable technologies 
and mobile health applications may play a special role, as the 
market for wearable (medical) devices is a booming market 
with the momentum to significantly change the healthcare 
system as we know it [8]. Especially these wearable devices 
“are already revolutionizing biomedicine through mobile 
and digital health by enabling continuous, longitudinal 
health monitoring outside of the clinic” [9]. Furthermore, 
they simplify the monitoring of non-bedridden patients 
within a clinic. The chances that can be realized through 
digital health and the widespread use of data driven medi-
cine can be shown considering the role of exogenous data 
(environmental influences), which can be integrated in data 
driven medicine but are oftentimes not used in traditional 
service provisioning. Moreover, traditional service provi-
sioning is largely based on clinical data. A key opportunity 
for using digital technologies could therefore be to enable 
the usage of all available data from various data sources (big 
data) for determining individual health conditions. These 
various forms of health data are nowadays generated at a 
massive scale and on different levels. However, the usage in 
todays healthcare systems is low [10], many systems are in 
a preliminary stage (development) and therefore do not have 
operational maturity [11]. Furthermore, broad penetration of 
healthcare delivery through medical devices raises severe 
concerns about patients safety, security and privacy [12]. 
The chances and threats trough implementation of digital 
technologies in healthcare delivery raises tensions between 
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the aim for a high quality care, resource efficiency (price 
efficient care) and the safety, security and privacy of patients 
and their health care information [12].
2.3.1  Chances of digital health applications for service 
delivery
As mentioned, transforming healthcare through digital 
health applications promises immense chances for service 
provisioning during pandemics. McCall [13] and Luengo-
Oroz et al. [14] focus on applications of AI to cope with the 
COVID-19 pandemic. McCall [13] builds on the experiences 
of the SARS epidemic in 2003 and compares the coping 
capabilities with those of SARS-CoV-2 in 2020. Within 
this work, McCall [13] focuses on the usage of AI to pre-
dict COVID-19 outbreaks and their location. Luengo-Oroz 
et al. [14] focus on global cooperation and data sharing as 
a special issue and a necessary prerequisite of using AI. 
However, they only show very briefly some chances arising 
from using AI for designing a more resilient healthcare sys-
tem with respect to pandemics. Kapoor et al. [15] focuses on 
the question of „how digital solutions can impact healthcare 
during (the) (…) pandemic” [15]. Within their work, they 
focus on the chances arising from a usage of digital solutions 
for healthcare (such as possibilities of tracking, telehealth, 
diagnostic support & information dissemination).
2.3.2  Risks for medial service provisioning
In May 2017, the WannaCry ransomware attack shed light to 
the threats of medical care dependence on digital technolo-
gies. This cyberattack was the first of its kind that caused 
severe disruptions of medical care delivery by causing digi-
tal medical devices (including medical imaging devices) to 
become non-operational. As a consequence, many hospi-
tals were forced to forward patients to other hospitals and 
withhold medical services as well as to divert ambulance 
routes [16]. The wide usage of information technology in the 
healthcare sector brings numerous security vulnerabilities 
that could be exploited by attackers [16].
However, since 2017, driven by the potentials of using 
digital solutions for healthcare for medical care delivery, 
the digitalization of the healthcare branch increased. Conse-
quently, medical care provision is facing new threats related 
to the increased penetration with information technology. 
These include the increased vulnerability (increased attack 
surface due to the medical internet of things; increasing 
inter-connections across hospitals and intra-connections 
within hospitals), increased exposure to potential attack-
ers (increasing attractivity of attacking healthcare provid-
ers; increasing interest in attacking the healthcare branch 
as a valuable target, e.g. ransomware attack on devices care 
delivery is highly dependent on) as well as increased impact 
(increasing effects of cyberattacks as there is a high depend-
ence on information technology in the modern healthcare 
branch).
2.3.3  Cost benefit tradeoffs
Keesara et al. [17] set the focus of their study on the com-
parison of the traditional analogous healthcare system and 
the benefits digital solutions for healthcare may bring to rev-
olutionize this system. Furthermore, they shed light on the 
necessity to adapt the healthcare system to the needs of our 
todays digitalized, technologized and globalized world. Fur-
thermore, they highlight barriers for the adoption of digital 
technologies (e.g. legal restrictions). Webster [8] compared 
selected experiences of clinicians with healthcare systems 
around the world. The work showed how different health-
care systems leveraged the power of information technology 
to deliver healthcare in the best possible quality during the 
COVID-19 pandemic. Although COVID-19 pushed digitali-
zation forward, Webster [8] questioned if the penetration 
with information technology is sustainable or just transient 
for the period of the pandemic. Furthermore, their work 
showed the need for increasing digitalization for coping 
with the constraints and restrictive circumstances during 
the COVID-19 pandemic worldwide. However, their work 
strictly focuses on privacy risks regarding a potential digi-
talization of health care services lacking in a broader per-
spective on the risks that come with an increasing depend-
ence on digital technologies such as security and safety risks 
and the wider effects of non-privacy preserving or insecure 
technology on public trust and the risks on healthcare tech-
nology adoption.
Our work aims to tackle this research gap and to forward 
scientific discussion on the question of where to reasonably 
apply digital technologies by giving a comprehensive over-
view about the chances and risks that are associated.
3  Healthcare during the pandemic
3.1  Effects of COVID‑19 on healthcare
During the COVID-19 pandemic, an overriding priority 
on diminishing the spread of COVID-19 was observed for 
all healthcare systems worldwide. However, the impact of 
COVID-19 on the treatment of medical conditions, which 
are not linked to the disease must not be underestimated 
[18]. As a reaction to the COVID-19 pandemic, many hos-
pitals “reduce or even cease many clinical services” [2]. 
Thereby two fundamental challenges arise concerning 
patient safety issues for patients with pre-disease. First, pre-
disposed patients must leave their homes to visit the clinic 
and thereby possibly expose themselves to the infection 
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[6]. Second, treatments themselves can predispose patients 
to more serious harmful effects of COVID-19 (e.g. cancer 
treatment) [6]. However, it is clear that postponing medical 
care cannot be done without time restrictions [2]. Postpone-
ments therefore need to prioritize the importance of medi-
cal care weighting the potential risks of pushing treatments 
forward with the risk of being infected by SARS-CoV-2 and 
the risks that may come with a postponement of medical 
interventions (e.g. risk for metastasis). The COVID-19 pan-
demic however revealed existing bottlenecks within many 
healthcare systems around the world with respect to critical 
care due to improper capacities (e.g. ventilators). Therefore, 
in many countries patients need to be postponed although 
they were infected by the virus and prioritizations of patients 
were undertaken. This stands in clear conflict with moral 
and ethical principles, in particular the Hippocratic Oath, 
which demands to provide the best medical care as possible 
to diminish harm and suffering. Therefore, the retention of 
capacities for urgent cases is prohibited as the denial of med-
ical care would lead to a suffering from deprivation. Thus, 
non-COVID-19 patients must not be discriminated [19].
Cancer care is one example, where postponing medi-
cal care might be critical as without treatment the risk for 
metastasis increase [20]. However, cancer treatments such 
as surgeries are oftentimes postponed and laboratory evalu-
ations delayed [20] [18]. Furthermore, post-operative care 
and aftercare examinations were suspended endangering 
the efficiency of cancer treatments. Yet, this may lead to 
increasing rates of readmissions. Moreover, cancer diagno-
sis was affected by COVID-19 as physician consultations 
were oftentimes postponed and diagnostic evaluations were 
delayed due to resource restrictions [21] [18]. This might 
be critical to the individuals health condition as early detec-
tions are essential for cancer treatment and advanced forms 
of cancer are oftentimes less amenable to medical interven-
tions [22]. Salako et al. [23] predict that with changed treat-
ment procedures during the COVID-19 pandemic medical 
outcomes will worsen, leading to higher mortality rates due 
to improper treatment. However, oncological care outcomes 
must not be compromised while minimizing patients expo-
sure to SARS-CoV-2 [24].
3.2  Modelling oncological care processes
3.2.1  Methodology for modelling health care processes
Various methods for modeling processes exist. These include 
business process model and notation (BPMN) and Integra-
tion Definition (IDEF). IDEF is a set of process modelling 
techniques including six specifications (IDEF-0 – IDEF-
5). The most commonly used form of IDEF modelling is 
IDEF-0 modelling, which is also used in this work. IDEF-0 
was chosen because it allows an intuitive representation and 
a process oriented mapping of information technology along 
the healthcare value chain which is essential for discussing 
the potentials and risks of an increasing penetration with 
information technology and new technological innovations 
in healthcare for supporting our healthcare system during a 
pandemic.
IDEF-0 models are represented as a graphic description 
with the format of boxes and arrows. The basic components 
of an IDEF-0 model are shown in Fig. 1. The boxes in the 
IDEF-0 model are used to represent functions and arrows 
depict constraints [25]. The function is responsible for the 
transformation of input material flows into outputs by using 
diverse resources under control constraints [26].There are 
four arrow classes including input, output, control and 
mechanism arrows. The activity transforms input data or 
objects into output material flows, which is represented by 
input and output arrows [25]. The control-arrow above the 
activity box represents the required conditions for the output 
production such as rules, regulations, policies, etc. [25]. The 
mechanism-arrow below the activity box represents tools, 
methods, and different resources for the activity execution 
[25].
3.2.2  Oncological care delivery model
In the following, a model of breast cancer care will be pre-
sented. The example was chosen because oncology patient 
treatment procedures have been affected severely through 
COVID-19 as patients are a highly vulnerable group due 
to their immunocompromised health condition. The high 
vulnerability for SARS-CoV-2 is thus caused by cancer 
itself but also by the treatment of cancer relying heavily 
on the intake of immune system suppressing drugs [27]. 
Figure 2 presents a process model, which gives a basic 
understanding of medical care provision and the effects 
of the COVID-19 pandemic on care provision using the 
example of breast cancer care. The model is based on 
IDEF0. The processes P1.1—P1.4 describe the diagnostic 
Fig. 1  IDEF-0 model components
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phase while P2.1—P2.4 describe the treatment phase for 
metastatic cancer where palliative care must be chosen and 
P2.1 -P2.4 describes curative therapy for early, localized 
or operable breast cancer. P3 represents post-therapy care.
The first phase of clinical breast cancer care is the 
diagnosis. Clinicians evaluate the health condition of the 
patient confirming a breast anomaly [28]. The confirma-
tion of a breast cancer diagnosis requires an evaluation 
of the stage of the disease, the selection of a therapy, and 
subsequent tests including imaging (mammography, ultra-
sound and MRI) and a biopsy [29]. If the cancer can be 
treated, there are some standard treatment options includ-
ing the surgery options of a breast-conserving surgery 
(lumpectomy) and a modified radical mastectomy [29]. 
Systemic therapies include e.g. adjuvant therapies like 
a chemotherapy [29]. However, if the cancer cannot be 
treated, clinician health care processes are limited to pal-
liative care of the patient such as pain management [28]. 
Post-therapy considerations include surveillance and hor-
mone replacement therapy [29].
As identified in the literature, there are several bottlenecks 
in health care provision for cancer patients which relate to 
surgeries, laboratory evaluations (esp. pathology), diagnostic 
processes and postoperative care [20] [18]. These main bot-
tlenecks (processes) are represented within the breast cancer 
treatment process model (Fig. 2) in red.
Thereby it is an essential duty of modern healthcare 
systems during a pandemic to minimize deprivation costs 
stemming from a lack of medical care. However, the costs 
of suffering from a lack of medical care need to be weighed 
against the risks of potential infections when deciding on 
whether to treat a patient or postpone medical interventions.
4  Literature review on existing technologies 
to tackle the COVID‑19 pandemic
4.1  Methodology
As it was stated by Ienca and Vayena [30], SARS-CoV-2 
emerged in a very digitized world, which bears many pos-
sibilities to contain and cure the COVID-19 disease by lev-
eraging the power of data and digital health. We conducted 
a systematic literature review to investigate implemented 
technologies and potentially useful technologies to cope 
with the effects of the COVID-19 pandemic.
For systematically assessing literature regarding the use 
of digital technologies for healthcare delivery during the 
COVID-19 pandemic we used the literature database Sco-
pus. We defined the inclusion criteria presented in Table 1. 
For setting the thematic focus on digital health solutions 
are extracted keywords from the work of Ahmadvand et al. 
[31] elaborating on keywords linked to the term digital 
health (most frequently linked terms include inter alia 
"mobile health", "mhealth", "health IT", "telehealth", and 
"telemedicine"). The literature search was conducted in 
July 2020.
The resulting literature search included 346 articles, 
which were further investigated. 96 articles need to be sorted 
out because they were not of interest for this study. There-
fore, the resulting literature review consists of 250 articles. 
Figure 3 presents the articles by country. Within this presen-
tation, we used a limit of 5 article contributions per country 
for the sake of clarity, if a country has less article contribu-
tions we summarized these within the category “Other”. It 
can be seen that especially countries heavily influenced by 
Fig. 2  IDEF0 model of breast cancer healthcare
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COVID-19 elaborated on possible use cases of digital health 
for medical service delivery.
We categorized digital health applications and medical 
devices deductively within the categorization of medical 
processes and organizational processes. Furthermore, we 
clustered medical processes in a more detailed way within 
the categorization provided by Naudé [11] (“tracking and 
prediction”, “diagnosis and prognosis”, “treatments and vac-
cines”, and “social control”).
5  Results
5.1  General overview of the application of digital 
health applications
The systematic literature review shows that especially during 
the COVID-19 pandemic digital health technologies (e.g. 
tele-diagnosis or telecare) helped substantially to make the 
healthcare system more resilient and efficient by provid-
ing healthcare solutions to a wide array of value processes. 
Digital technologies may for example “enable that patients 
have access to physicians (…) while remaining safely at 
home” [32] and without exposing themselves to the risk of 
an infection. For some vulnerable groups, telehealth solu-
tions can even be the only way to access healthcare. Tel-
emedicine may therefore help to ensure that everybody gets 
access to medical care [33]. However, besides these aspects 
where digital health technologies are considered helpful 
or are used in primary value processes (e.g. diagnosis and 
treatment) [33] [34], technological advances are also used in 
supportive processes (so called secondary value processes) 
[35] [34] [36]. However, there is a strong focus of research 
on the effects and usage of digital technologies for primary 
value processes. Furthermore, tracking and prediction as 
well as social control are further processes associated with 
healthcare delivery that can be supported by digital health 
[37]. Hence, digital health applications provide solutions or 
are as least discussed to be able to deliver solutions for all 
processes within medical service delivery including medi-
cal processes as well as organizational processes [36]. The 
frequency of keywords can here be seen as a proxy of the 
Table 1  Literature search
Criteria Inclusion
Thematic focus on the COVID-19-pandemic Title, abstract or keywords include the terms COVID*, corona or SARS-CoV-2
Thematic focus on digital health solutions Title, abstract or keywords include the terms digital health, mobile health, mhealth, 
health IT, health information technology, wearable devices, telehealth, telemedicine 
or personalized medicine
Publications are recently published and peer reviewed Publication stage is final, publications are from peer reviewed journals and the year of 
publication is 2020
Language of publication is English Language of publication is English
Resulting search term TITLE-ABS-KEY(("COVID*" OR "corona*" OR "SARS-CoV-2") AND ("digital 
health" OR "mobile health" OR"mhealth" OR "health IT" OR "health information 
technology" OR "wearable devices" OR "telehealth" OR "telemedicine" OR "per-
sonalized medicine")) AND ( LIMIT-TO ( PUBSTAGE,"final")) AND ( LIMIT-TO 
( PUBYEAR,2020)) AND ( LIMIT-TO ( DOCTYPE,"ar")) AND ( LIMIT-TO ( 
LANGUAGE,"English"))
Fig. 3  Articles by country
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expected usefulness, since it can be assumed that only those 
technologies with a high number are included in the scien-
tific discourse, which promise a significant benefit.
In the countries of India and China robots are for exam-
ple used to assist frontline healthcare workers (especially 
nurses) by delivering food and sanitizing [38]. In situations 
like the COVID-19 pandemic, digital health devices deliver 
valuable data for public decision-making. However, it does 
also deliver valuable data for clinical decision-making and 
can aid in healthcare processes like diagnosing, managing 
and treating as well as in prediction of the course disease. 
Thereby also fitness trackers may deliver valuable insights, 
which can be used to improve care delivery and enable (even 
personalized) health care interventions.
Furthermore, IoT devices can be used for medical imag-
ing [35]. Robotic ultrasound equipment can be used for 
remote high resolution diagnostic imaging [39]. Digital 
health solutions can be used for evaluation and suggestion 
of therapies [40]. This can be based on predictions regarding 
clinical outcomes [38]. Furthermore, robots are useful for 
assistance in surgeries and can be combined with informa-
tion and telecommunication technologies for enabling tele-
surgeries [40]. Additionally, robots can assist in treatments 
of patients, perform online medical examinations and per-
form real time monitoring [35]. However, the most common 
use case is the enablement of tele-medical communication 
and virtual patient visits. AI and information technology can 
be used to support diagnosis (e.g. screening) and treatment 
(individual ventilator settings) [38]. Furthermore, secondary 
value processes like drug development and other services 
(e.g. providing food taking care, sanitizing, and surveillance) 
can be supported by digital health solutions [38]. Further-
more, virtual reality can be used for training purposes [35]. 
Besides medical processes in the narrow sense, digital health 
solutions can be used for tracking and tracing health condi-
tions within a society and controlling the compliance with 
prescribed procedures (e.g. wearing masks). Based on the 
big amount of data valuable predictions can be generated 
by leveraging the power of AI (forecasting, classification, 
identification of health conditions like COVID-19 and ill-
nesses that come with similar symptoms but are not linked 
to COVID-19, alerts, and trace infection hubs) [35] [38].
Figure 4 visualizes the shares of articles elaborating 
on using digital health applications for different processes 
of medical care and therefore the expected usefulness of 
including means of digital health to those processes. The 
upper part of the figure shows major processes of medical 
care systems while the lower part visualizes the usage of 
digital health in specific subprocesses. The literature review 
reveals a focus of scientific research on the support of medi-
cal processes (diagnosis and prognosis and treatments and 
vaccines). Within medical processes, the main potential of 
including digital health applications to medical care during 
pandemics is seen in enabling patient consultations by vir-
tual means followed by possibilities for remote monitoring 
and remote interventions.
Fig. 4  Shares of articles proposing the use of digital health in the respective medical care process
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Figure  5 gives an overview of the usage of digital 
health devices in different medical departments. It needs 
to be emphasized that digital health solutions are used in 
some medical disciplines since many years (e.g. oncol-
ogy, endocrinology esp. diabetes care and psychiatry) 
[41]. However, the adoption of digital technologies in 
other specialties is much weaker. Furthermore, a large 
amount of articles dealt with the usage of digital health 
applications during the COVID-19 pandemic in general 
(“not specified”).
5.2  Applications in oncological care
For mapping the digital health solutions to the processes of 
breast cancer care, we restricted our review only on those 24 
articles dealing with oncological care. Thereby secondary 
value processes were not in the focus of the publications (see 
Figs. 6 and 7). Instead, they focus merely on the specifics 
of treatment of oncological diseases and therefore do not 
include general usage of digital solutions for increasing the 
efficiency of healthcare delivery. Furthermore, it catches the 
Fig. 5  Distribution by medical 
department
Fig. 6  Shares of articles dealing with different processes of oncological care
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eye that virtual patient visits are most frequently considered 
as a possible use case of digital technologies in oncological 
care (like it was also focused most frequently for all medical 
departments). Additionally, the possibilities of using digital 
health applications for diagnosing are discussed frequently 
(usage of digital health applications for “early detection”, 
and “telediagnosis”). Last, “telemonitoring” and the usage 
of digital health for enabling interventions is considered to 
be beneficial. However, the potential for enabling interven-
tions can be estimated to be lower in oncology compared to 
the overall use in medicine.
5.3  Mapping to the IDEF0 model
Digital technologies may help to overcome at least some 
challenges in cancer care delivery so that in some cases 
cancer treatment could be done virtually [42]. An example 
for the possibilities is the usage of AI to enable the evalua-
tion of big data generated through digital technology, which 
enabled wide screening of mammograms while overcom-
ing high false positive rates in human expert predictions 
[22]. This makes it possible to overcome some bottlenecks 
in diagnosing cancer diseases and can therefore diminish 
the burden to clinicians. Thus, the caseload of a clinician 
could be increased in order to cope with the high number 
of patients during a pandemic. However, there will remain 
some bottlenecks in healthcare (see red processes in Fig. 7) 
where information technology currently does not provide 
significant help including imaging and pathology processes. 
The reason is that digital solutions for healthcare are strong 
in e.g. recognizing patterns in images and derive treatments 
(decision support) but do not provide solutions for the prob-
lem of shortages in information technology that generates 
these images (e.g. shortages in computer tomography (CT) 
machinery). For specific applications, medical technology 
has higher requirements than widely adopted, “classic” 
smart technologies. For example, although smartphone cam-
eras could theoretically be used for medical imaging [34], 
these technologies are not able to take medical useful images 
in the case of breast cancer. Therefore, these technologies 
are not suitable for medical imaging. Furthermore, digital 
solutions for healthcare can help to decrease the burden in 
treating patients (e.g. decision support). The technologies, 
which are especially useful for medical care of breast can-
cer patients include telehealth services (teleconsultations, 
tele-diagnosis, and tele-monitoring), which is also useful for 
decreasing crowded waiting rooms and hence the risk of an 
SARS-CoV-2 infection, and monitoring of health conditions 
leveraging the power of wearables and other smart devices 
(using health applications).
6  Discussion
6.1  Chances of introducing digital health to cope 
with pandemics
Digital technologies can be used to support healthcare pro-
vision in many ways [43]. Digital solutions for healthcare 
can be used in diagnosis (e.g. computer aided detection 
Fig. 7  Digital solutions for healthcare in breast cancer healthcare
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(CAD), tele-diagnosis, AI assisted decision making, 
screening; e.g. breast cancer screening [22]), treatment 
(e.g. decision support based on AI, symptom manage-
ment and monitoring of health conditions, tele-surgery) 
and aftercare (e.g. monitoring of health conditions) to 
overcome decision errors (i.e. high false positive rates in 
breast cancer diagnosis undertaken by healthcare profes-
sionals) [43]. Furthermore, digital solutions for healthcare 
may be a means to enable access to medical care for hard 
to reach populations through telehealth and the empower-
ment of patients in care provision. Furthermore, digital 
health including AI can be used to detect diseases, for 
predicting disease progression as well as enabling broad 
screenings among large parts of the society [2] [13] [14].
Furthermore, for public information dissemination also the 
internet of things (IoT) can be used [2]. AI and Deep Learning 
can be used to fight disinformation [14]. Besides, these tech-
nologies can be used to create human like chat bots, which can 
deliver information in a more accessible way. Using all avail-
able types of data (e.g. genome data, protein structure, clinical 
data, medical image data, case statistics, epidemiological data, 
mobility statistics, and scientific research outcomes) is chal-
lenging. Therefore, big data analytics is necessary to leverage 
all potentials of using medical data.
Furthermore, the inclusion of such technologies may 
provide a benefit to patients and empowers their role in 
care provision (e.g. self-monitoring) [43]. Digital solu-
tions for healthcare may therefore leverage the power of 
medical data processing and analysis, health data min-
ing as well as health data modelling for computer-aided 
healthcare (such as computer-aided diagnosis and com-
puter-assisted surgery). Using digital technologies for 
healthcare may furthermore increase the caseloads of 
physicians without increasing the workload as physicians 
can focus themselves on their task without being dis-
tracted by routine tasks that could easily be done by digi-
tal health solutions [32] [35]. Furthermore, travel times 
can be minimized and thus further diminish the workload 
of physicians [35] and speed up some processes. This is 
because the assistance through digital health applications 
may simplify (e.g. through the takeover of administrative 
issues) or even take over significant parts of the provi-
sion of medical care. Additionally, patient consultations 
could happen largely virtually [32]. Digital solutions for 
healthcare like online cognitive behavioral therapies or 
counselling services pose great chances for care delivery 
and are widely used for (especially mental) care provision 
[44]. Therefore, information technology may contribute 
to holistic healthcare provision and precision medicine. 
Additionally, digitalization of healthcare can be seen as 
a means for making medical service provisioning more 
(at least socially and economically) sustainable even in 
extreme situations (e.g. during pandemics).
Furthermore, digital health could be and is already used 
in research for identifying applications of known drugs to 
the cure of new diseases (e.g. COVID-19) [13] or accelerat-
ing the development of innovative digital health care appli-
cations [14]. However, there is a need of high quality input 
data [13]. Application areas of digital solutions for health-
care in research are for example AI assisted drug discovery 
and discovery of vaccines [33].
These chances of including digital solutions for health-
care may improve patient care. However, the increasing 
usage of mobile applications like health apps or wearables 
may further increase the potential of digital solutions for 
healthcare as data availability increases with the increas-
ing share of mobile application usage. Although there are 
big chances of using digital solutions for healthcare, so far 
there is only limited usage in general. Furthermore, usage 
of such technologies is oftentimes limited to specific phases 
of care provision and predominantly used for curing spe-
cific diseases (e.g. diabetes, psychological disorders) [43]. 
However, “there should be a higher degree of pervasiveness 
at all stages and in all health care delivery activities” [43].
6.2  Risks of digital health devices
Besides the immense opportunities inherent in a wide usage of 
digital solutions for healthcare, the strong dependence on digi-
tal health infrastructure increases the vulnerability of health-
care service providers to cyberattacks. Especially during a 
pandemic where work- and caseload for physicians is very 
high, these cyberattacks may have an immense impact on the 
proper functioning of healthcare provision. An outage of digi-
tal solutions could then lead in the worst case to a complete 
quiescence of operations, which would have severe effects on 
health care value. Consequently, the impact of a cyberattack 
may get more severe if service provisioning is highly depend-
ent on digital solutions for healthcare. Therefore, attacking 
health care providers may get more attractive [45].
As a consequence, privacy and security are essential 
for the acceptance of digital health but cyber threats rep-
resent a significant barrier for the implementation of digi-
tal solutions in healthcare [14]. For example, tracing and 
tracking apps (like they were in use during the COVID-19 
pandemic) may represent a significant threat to health data 
privacy and also to human rights in general. These tracing 
and tracking applications rely on the assumption that gain-
ing “control of the pandemic requires (gaining) control of 
people” [1]. However, these applications may pose severe 
restrictions of basic human rights as authorities widely 
collect more data than an individual may agree on when 
deciding rationally [11]. Especially past crises should be 
alarming when deciding about solutions compromising 
human rights as they proved that regaining these rights can 
be hard [1] [46]. Thus, it is essential for digital solutions 
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for healthcare that they respect basic human rights, also 
during pandemics [46].
However, as there may be a high necessity to develop 
these innovative digital health care solutions (e.g. during 
a pandemic) there is a shortage of time for development. 
The immense time restrictions of developing solutions e.g. 
for the COVID-19 crisis poses the necessity of prioritizing 
[14]. Thereby security and privacy must not be neglected (as 
discussed). The actionist development of digital solutions 
for healthcare and frugal innovations during the COVID-
19 crisis can be seen as an example. Many digital solu-
tions for healthcare were introduced during that time [46]. 
However, it was shown that the majority of applications to 
cope with COVID-19 compromised essential human rights 
(especially privacy rights) [46]. Therefore, there are severe 
concerns about the threats that are posed by digital solu-
tions for healthcare (that are not constructed with a focus 
on security and privacy) to human rights [14]. “Useful as 
these are, the fear is that once the outbreak is over, that ero-
sion of data privacy would not be rolled back and that gov-
ernments would continue to use their improved ability to 
survey their populations” [11]. These concerns may limit 
the acceptance of digital health care solutions by society in 
a long term and may hamper trust in medical devices and 
authorities [11].”Data breaches, insufficient or ineffective 
de-identification and biases in datasets can (consistently) 
become major causes of distrust in public-health services “ 
[30]. Therefore, privacy and security is essential for digital 
health solution providers to be able to build trust in the usage 
of digital health solutions and use the chances that are inher-
ent to the use of these technologies [45].
The COVID-19 pandemic boosted adoption of digitalized 
healthcare. However, there was no wide readiness within the 
healthcare systems in many countries. For example, there 
were oftentimes lacks in necessary hardware and technical 
knowhow to enable digital care delivery [32] [47]. Further-
more, technological solutions for healthcare pose their own 
specifics on medical staff such as knowledge about how to 
work with these technological solutions properly. The ques-
tionable readiness of many healthcare systems to adopt and 
integrate these technologies into their daily operations could 
thus have led to an increased susceptibility for cyber risks and 
to the fact that the chances were not entirely realized. Hence, it 
could not be observed that digitalized healthcare systems were 
able to cope with COVID-19 significantly better. Additionally, 
the COVID-19 crisis showed that cyberrisks need to be taken 
seriously as the dependence on digital technology increased 
when traditional means of delivering healthcare were lim-
ited severely. This can also be seen in the increasing num-
ber of cyberattacks during the COVID-19 pandemic [3]. It is 
therefore essential to design digital healthcare systems with a 
strong focus on security and privacy. Thus, the engineering of 
secure systems for healthcare services is imperative.
7  Conclusion and implications
The COVID‐19 pandemic could alter sustainably medical 
practice [48]. Hence, it is important to jointly discuss the 
chances and risks that come with an increasing penetration 
with digital health solutions. With the intent to forward sci-
entific discussion on the cost–benefit tradeoffs on digital 
health devices, this article gives an overview of the influence 
of digital solutions on the healthcare sector by relying on a 
multi methods approach. Based on recent research presented 
in literature, the chances as well as the risks arising from an 
inclusion of digital solutions for healthcare on medical care 
provision are presented with a special focus on the resilience 
of healthcare systems during a pandemic. In particular, the 
work presents a process model of care delivery and maps 
technological usage to the affected processes.
Pandemics may disrupt traditional (non-digital technol-
ogy based) care delivery processes (e.g. during the COVID-
19 pandemic), the importance of including digital solutions 
for healthcare rises. Thus, increasing the wide adoption of 
digital technologies in healthcare could decrease the bur-
den to clinicians in pandemics and hence increase the resil-
iency of our healthcare systems. As digitalization of many 
areas in medical service provisioning is a fact, choosing the 
right digitalization strategy gains in importance for mod-
ern healthcare systems around the globe. The adoption and 
usage of digital technologies in healthcare is thereby mainly 
driven by the tradeoff between healthcare costs and quality 
of services (benefits). While the discussion on healthcare 
digitalization oftentimes focuses on the chances and direct 
monetary costs, risk are overlooked or considered insuffi-
ciently. Consistently, many risks that come with the adoption 
of digital health technologies are only discussed and even 
understood inadequately.
This work aims at highlighting the needs and sharpen-
ing the awareness that decisions on the adoption of digi-
tal health systems should be based on a comprehensive/ 
holistic assessment of both costs and risks. We therefore 
give an overview over the chances and risks arising from 
the adoption of digital technologies with a special focus 
on healthcare during pandemics. We show that there are 
great opportunities for a long number of processes includ-
ing organizational processes (secondary value processes) as 
well as primary processes of medical service provisioning 
(including diagnosis and treatment). However, it need to be 
ensured that patient safety and data privacy is not jeopard-
ized trough cyberattacks. Therefore, engineering secure 
systems and guaranteeing security, safety and privacy when 
using digital solutions for healthcare is a necessary prereq-
uisite for being able to leverage on the power of an inclusion 
of digital technologies in healthcare. We furthermore take 
a multi perspective view on the chances and risks including 
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social, economic and medical points of view. Moreover, we 
include a wide array of different risks (inter alia privacy and 
security risks) to our analysis.
The COVID-19 pandemic should be used as a natural 
experiment to analyze the effects of shifting processes to 
digital areas. Hence, in aftermath of the pandemic effects 
of improper service provisioning should be evaluated. Fur-
thermore, the effects of digital health technologies should 
be considered. Thereby a focus should not only be set on 
whether digitalization increased the efficiency and effective-
ness of service provisioning but also on cyber risks and the 
susceptibility of healthcare provisioning systems.
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